prediabetes and semaglutide RCT: In patients with #schizophrenia, #prediabetes, #obesity, once-weekly #semaglutide injections, up to 1.0 mg/week, were safe and effective. https://t.co/u7CwGLDs1E Semaglutide in Patients With Schizophrenia,

Effects of GLP-1 Agonists on Fat Mass & Lean Mass: Initial body composition data from a short-term (12-week) Semaglutide treatment observed a 5kg change in body mass, with 70% (3.5kg) of that from fat mass and 22% (1.1kg) from lean mass [14]

The doctor will ask you about what you eat and if you have other health conditions

Phase 3 trials include extended monitoring periods that will provide crucial information over the coming years

Generally, the clinical aspects of pigmented lesions in the oral cavity are sufficient in establishing the diagnosis

Saxenda European Public Assessment Report

We will look at their uses, how they work, and why people find them helpful